Zimmer Biomet Holdings (NYSE: ZBH) reported Q1 EPS of $1.81, $0.04 better than the analyst estimate of $1.77. Revenue for the quarter came in at $1.91 billion versus the consensus estimate of $1.89 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2025 EPS of $7.90-$8.10, versus the consensus of $8.21.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.